Overview

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine the feasibility of attaining acceptable rates of donor cell engraftment (>25% donor chimerism at 180 days) following reduced intensity conditioning (RIC) regimens in pediatric patients < 21 years receiving cord blood transplantation for non-malignant disorders.
Phase:
Phase 1
Details
Lead Sponsor:
Duke University
Treatments:
Fludarabine
Hydroxyurea
Melphalan
Thiotepa